|
End-of-day quote
Other stock markets
|
||
| - GHS | - |
|
| Market Cap | 5.2M 57.71M 4.53M 4.17M 3.93M 7.34M 490M 7.4M 49.66M 19.28M 241M 19.5M 19.09M 837M | P/E 2017 |
11.7x | P/E 2018 | 6.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.45M 116M 9.1M 8.39M 7.89M 14.76M 984M 14.87M 99.82M 38.77M 485M 39.21M 38.37M 1.68B | EV / Sales 2017 |
1.34x | EV / Sales 2018 | 1.05x |
| Free-Float |
26.89% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.00% | - | - | 915K | ||
| -1.57% | -5.87% | +39.20% | +141.78% | 992B | ||
| -2.65% | -4.31% | +51.30% | +38.95% | 564B | ||
| -2.19% | -3.93% | +16.41% | +56.68% | 391B | ||
| -2.90% | +0.68% | +24.66% | +16.53% | 330B | ||
| -2.36% | -3.12% | +24.71% | +12.95% | 280B | ||
| -2.45% | -2.88% | +24.29% | +29.93% | 279B | ||
| -1.91% | -0.87% | -41.95% | -48.26% | 196B | ||
| -1.66% | -5.21% | +15.88% | +46.82% | 184B | ||
| -2.21% | -2.41% | +13.74% | +58.07% | 156B | ||
| Average | -2.30% | +0.41% | +18.69% | +39.27% | 337.12B | |
| Weighted average by Cap. | -2.21% | -0.49% | +27.55% | +62.40% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 8.89M 98.76M 7.75M 7.14M 6.72M 12.57M 838M 12.66M 84.98M 33M 413M 33.38M 32.66M 1.43B | 9.91M 110M 8.63M 7.96M 7.49M 14.01M 934M 14.1M 94.69M 36.78M 460M 37.2M 36.4M 1.6B |
| Net income | 665K 7.39M 579K 534K 502K 940K 62.68M 947K 6.35M 2.47M 30.89M 2.5M 2.44M 107M | 762K 8.46M 664K 612K 575K 1.08M 71.77M 1.08M 7.28M 2.83M 35.37M 2.86M 2.8M 123M |
| Net Debt | 4.15M 46.06M 3.61M 3.33M 3.13M 5.86M 391M 5.9M 39.63M 15.39M 193M 15.57M 15.23M 668M | 5.25M 58.31M 4.57M 4.22M 3.97M 7.42M 495M 7.47M 50.17M 19.48M 244M 19.7M 19.28M 845M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
















